Is it now time to prepare psychiatry for a psychedelic future?

Published in: The British journal of psychiatry : the journal of mental science (2024)

Australia has just rescheduled two drugs controlled under the United Nations Psychotropic Drug Conventions, psilocybin and MDMA, as treatments for treatment-resistant depression and post-traumatic stress disorder respectively. This feature explores the reasons for these developments, the opportunities and challenges they provide to psychiatry communities and how along with health systems these communities might respond to these developments.

Keyphrases

depressive symptoms
machine learning
current status
sleep quality
drug induced
social support
emergency department
adverse drug
neural network